Cargando…

COVID-19 Vaccination in Patients with Inflammatory Bowel Disease: A Survey from China

Detalles Bibliográficos
Autores principales:	Dai, Cong, Jiang, Min, Huang, Yu-hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375283/ https://www.ncbi.nlm.nih.gov/pubmed/34410574 http://dx.doi.org/10.1007/s10620-021-07169-x

Ejemplares similares

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
por: An, Ping, et al.
Publicado: (2020)

Letter to the Editor on “Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease Patients During the SARS-CoV-2 Pandemic”
por: Dai, Cong, et al.
Publicado: (2021)

Low frequency of COVID-19 in inflammatory bowel diseases
por: Marafini, Irene, et al.
Publicado: (2020)

Impact of Medication Discontinuation on Patients With Inflammatory Bowel Disease During the COVID-19 Outbreak
por: Chen, Junrong, et al.
Publicado: (2021)

COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution
por: Levine, Irving, et al.
Publicado: (2022)

Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease”
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

The Associations Between Pharmacologic Gastric Acid Suppression and Adverse Outcomes in Patients With COVID-19
por: Dai, Cong, et al.
Publicado: (2021)

Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era
por: Nardone, Olga Maria, et al.
Publicado: (2020)

The Course of COVID-19 in Inflammatory Bowel Disease: Protective Role of TNF Antagonists
por: Cappello, Maria, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic
por: Kotze, Paulo Gustavo, et al.
Publicado: (2021)

Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19
por: Bhat, Shubha, et al.
Publicado: (2021)

Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic
por: Viola, Anna, et al.
Publicado: (2021)

Adalimumab for treatment of very early onset inflammatory bowel disease
por: Xie, Yao, et al.
Publicado: (2019)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
por: Alexander, James L, et al.
Publicado: (2021)

Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak
por: Zingone, Fabiana, et al.
Publicado: (2020)

Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
por: Alexander, James L, et al.
Publicado: (2021)

SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
por: Selim, Rania, et al.
Publicado: (2021)

Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology–Surgery Team to Include an Infectious Disease Specialist
por: Bezzio, Cristina, et al.
Publicado: (2021)

The future of robotic surgery for inflammatory bowel diseases
por: Gul, Fahad, et al.
Publicado: (2022)

Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients’ Survey
por: Caron, Bénédicte, et al.
Publicado: (2021)

The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”
por: Pugliese, Daniela, et al.
Publicado: (2020)

Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2021)

Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
por: Barberio, Brigida, et al.
Publicado: (2021)

The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
por: Barberio, Brigida, et al.
Publicado: (2021)

The Courage to Return to Everyday Life at the Time of COVID-19: The Point of View of Inflammatory Bowel Disease Patients Needing Endoscopy
por: Mocciaro, Filippo, et al.
Publicado: (2021)

Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19()
por: Pellegrino, Raffaele, et al.
Publicado: (2022)

Inflammatory bowel disease in Lebanon: a plea for help
por: Mourad, Fadi H, et al.
Publicado: (2022)

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease
por: Wellens, Judith, et al.
Publicado: (2022)

SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
por: Alexander, James L, et al.
Publicado: (2021)

Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy
por: Selim, Rania, et al.
Publicado: (2022)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic
por: Jena, Anuraag, et al.
Publicado: (2021)

Ocular inflammatory events and COVID-19 vaccination: correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
por: Kuenzig, M Ellen, et al.
Publicado: (2022)

Telemedicine: A promising future for inflammatory bowel disease management
por: Fazal, Faizan, et al.
Publicado: (2022)

Urgent surgery for inflammatory bowel diseases during the COVID-19 outbreak in a high incidence area - Experience from a high-volume centre
por: Botti, Fiorenzo, et al.
Publicado: (2020)

Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease
por: Saad-Hossne, Rogerio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g8rb3rvpslind27i9o8n3uh42m